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Novelty and Impact: Traditionally there have been large differences in cancer incidence 
across geographic regions, and even though this picture is changing with changes in lifestyle-
related cancers in low-income countries, geographic differences still exist. We have 
compared cancer incidence in immigrant groups with that in individuals born in Norway, and 
have found surprisingly large differences for some cancers. The Norwegian setting is well 
suited for these studies because of the complete cancer registration and universal public 






Traditionally there have been differences in cancer incidence across geographic regions. 
When immigrants have moved from low-income to high-income countries, their incidence 
have changed as they have adapted to the lifestyle in the new host country. Given worldwide 
changes in lifestyle factors over time, we decided to examine cancer incidence in immigrant 
groups in Norway, a country with a recent immigration history, complete cancer registration 
and universal public health care. We linked immigration history for the complete population 
to information on cancer diagnosis from the Cancer Registry of Norway for the period 1990-
2012. Age-standardized (world) overall and site-specific cancer incidence were estimated for 
different immigrant groups and compared to incidence among individuals born in Norway. 
Among 850 008 immigrants, 9158 men and 10 334 women developed cancer, and among 
5 508 429 Norwegian-born, 263 316 men and 235 020 women developed cancer. While 
incidence of breast and colorectal cancer were highest among individuals born in Norway and 
other high-income countries, other cancer types were higher in immigrants from low-income 
countries. Lung cancer incidence was highest in Eastern European men, and men and women 
from Eastern Europe had high incidence of stomach cancer. Incidence of liver cancer was 
substantially higher in immigrants from low-income countries than in individuals born in 
Norway and other high-income countries. Our results mirror known cancer challenges across 
the world. Although cancer incidence overall is lower in immigrants from low-income 
countries, certain cancers, such as lung, liver and stomach cancer, represent major challenges 






Cancer incidence and type distribution varies between countries and populations, with low- 
and middle-income countries, hereafter called low-income countries, generally having lower 
total cancer incidence than high-income countries (1). Infection-related cancer types, such as 
liver, stomach, and cervical cancers, have traditionally been more common in low-income 
countries, while cancers predominantly caused by a high-income lifestyle, such as lung, 
colorectal, and breast cancers, have dominated in high-income countries (2). However, in 
recent decades there has been a trend towards increasing occurrence of certain lifestyle-
related cancers, such as lung and breast, in low-income countries (1).  
Early studies of immigrants in the US found that they have higher cancer incidence 
than those who stay in their country of origin (3-5), a finding supported by a more recent 
study of Indian immigrants in Great Britain (6). Cancer incidence starts to increase the first 
decade after migration, coinciding with major lifestyle changes, and reaches the level of the 
population of the host country in 1-2 generations (7-9).  
Not only are lifestyle risk factors reported to be lower in immigrants than in the 
population of the host country at time of migration, but the overall health of immigrants have 
often been better than of those who stay in the country of origin, possibly as a result of 
selective migration, a phenomenon named the ‘healthy migrant effect’ (10). With time since 
migration, the immigrants adapt the new culture of the host population, which negates any 
‘healthy migrant effect’, and cancer incidence rises. Further, given the changing cancer rates 
globally, with rises in lifestyle-related cancers particularly in low-income countries, an 
important question is whether the ‘healthy migrant effect’ remains in people who migrated 
recently. If so, the first few years after migration offers a window of opportunity for cancer 
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prevention, before the immigrants assimilate the higher risk behavior of the new host 
populations (11). 
Immigration to Norway started relatively recently. Before oil was discovered in the 
1970s, Norway was a poor country, and the population of immigrants was negligible. With 
the economy boon of the 1970s, there was a rapid rise in the immigrant population (12), 
which is currently 16.3% (13). Immigration to Norway has been fragmented, both in relation 
to country of origin and reason for immigration, resulting in a heterogeneous immigrant 
population (12).  
The Norwegian setting is well suited for studies of cancer in immigrants because of 
the complete cancer registration and universal public health care coverage. Thus, we took 
advantage of the population based registries of country background and cancer to study 





Cohort and follow-up 
The cohort consisted of all individuals born between 1882 and 2011 who were registered as 
residents of Norway for 12 or more months during the period 1990-2012. In order to define 
the cohort and link various registries, we used the personal identification number (PIN) 
assigned all Norwegian-born at birth (or six months after immigration). Information on 
country of origin, country of origin of parents and grandparents, and date of immigration was 
obtained from the Norwegian Population Registry - Statistics Norway. Immigrants were 
defined as individuals born outside of Norway with a registered date of immigration (first 
generation immigrants), and Norwegian-born were defined as individuals born in Norway. 
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Included in the Norwegian-born population were individuals born in Norway of immigrant 
parents (second generation immigrants) (2.3% in 2013, with 77% under the age of 18 (14)). 
Immigrants were classified according to their country of origin. Countries were further 
collapsed into regions, broadly defined according to the WHO regional groupings (15), with 
some modifications based on number of immigrants from each country (Supplementary 
Material). We identified cancer cases in the data set during follow-up (January 1 1990 to 
December 31 2012) by linking the cohort to the Cancer Registry of Norway (CRN). Cancers 
are classified according to the 10th revision of the International Classification of Diseases 
(ICD-10), and we included codes C00-C96. The CRN has since 1952 systematically collected 
notifications on cancer occurrence for the Norwegian population, reporting has been 
mandatory by law since the start, and the registry is considered to be close to complete (16).  
 
Statistical analyses 
The study population consisted of 5 508 429 Norwegian-born (95.9% of the person-years) 
and 850 008 immigrants (4.1% of the person-years). Individuals were followed from their 
birth date (Norwegian-born) or their date of immigration (immigrants) until diagnosis of 
cancer, death, emigration from Norway, or December 31, 2012, whichever occurred first.  
We estimated age-standardized incidence rates (ASR) and 95% confidence intervals 
(CIs) (17) by region of origin for immigrants, as well as for Norwegian-born, using the age 
distribution from the world standard population (18, 19). The ASRs were calculated from 5-
year age groups, sex and time periods (5-year bands). In comparing cancer ASRs between 
different immigrant groups and Norwegian-born, non-overlapping 95% CIs were considered 
to represent difference in cancer ASRs (20). We calculated rates for total (C00-96) excluding 
non-melanoma skin (C44) cancer, hereafter called total cancer, as well as for certain common 
cancer types with high incidence worldwide (1) such as lung (C33-34), colorectal (C18-20), 
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prostate (C61), breast (C50), and cervix (C53), as well as for stomach (C16) and liver (C22) 
cancers as they are known to be more prevalent in certain immigrant groups (21). As rates 
based on small counts tend to have poor statistical reliability (22), three regions (Rest Africa, 
Oceania, and South/Central America) were only included in analyses of total cancer.  
For immigrants, we repeated the analyses excluding the first five years of follow-up, 
to eliminate prevalent cancer cases. However, as this restriction did not change the results 
notably (ASRs overall 261.7 versus 266.8 in men and 225.6 versus 235.1 in women), we here 
present results with all available data.  
To compare the immigrant groups to the rest of the population, we also calculated 
standardized incidence ratios (SIRs) as the ratio of observed to expected cases, using the 
incidence for all individuals born in Norway as the standard rate. CIs were calculated 
assuming a Poisson distribution. 
All statistical analyses were carried out using Stata version 14 (23). 






Most immigrants to Norway during this period came from other European countries 
(Supplementary Figure).  Immigrants from the Nordic countries consisted largely of Swedes 
and Danes, and immigrants from other Western European countries originated mostly from 
Germany and Great Britain. Eastern Europe comprised the largest immigrant group, and 
Poland was the country of origin for most immigrants. Outside Europe, most immigrants 
originated from East Asia or Sub-Saharan Africa (mostly Somalia) closely followed by South 
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Asia and the Middle East. The ratio of male to female immigrants varied considerably 
between countries. Among the Eastern European immigrants, 60% were men, while the 
number of Eastern Asian women was twice the number of Eastern Asian men. Median ages at 
immigration were 27 years for men and 25 years for women. Most immigrants (79% of men 
and 77% of women) were followed up 10 or more years before diagnosis of cancer. 
 A total of 498 336 cancer cases (263 316 in men and 235 020 in women) were 
recorded in Norwegian-born and 19 492 cancer cases (9158 in men and 10 334 in women) in 
immigrants during the follow-up from 1990 to 2012. Figure 1 shows the ASRs for total 
cancer by region of origin. The Norwegian ASRs (298.3 in men and 248.8 in women) 
exceeded the ASRs for all immigrants combined (266.8 in men and 235.1 in women). 
Immigrants from other European countries had ASRs similar to Norwegian-born, whereas 
immigrants from non-European low-income countries had lower ASRs. Immigrant men had 
higher ASRs of lung cancer than Norwegian-born men (37.4 versus 33.3), and especially high 
incidence was found among men from Eastern Europe (50.7) (Figure 2). Men from the other 
Nordic countries (41.6) also had higher rates than Norwegian-born men. Immigrant women 
had lower incidence (17.1) than Norwegian-born women (19.1), where women from high-
income countries, e.g. other Nordic (19.0) and other Western European countries (19.2), had 
similar ASRs to Norwegian-born women, and women from East Asia had a high ASR (17.9) 
compared with women from other low-income countries, e.g. the Middle East (6.3) and South 
Asia (6.3).  
For colorectal cancer, Norwegian ASRs (38.8 in men and 30.7 in women) were higher 
than the ASRs among the different immigrant groups, especially among immigrants from 
low-income countries, where the lowest ASRs were found in immigrants from South Asia 
(7.2 in men and 9.2 in women) (Figure 3). For prostate cancer, the Norwegian ASRs (78.5) 
exceeded ASRs for all immigrant groups however closely followed by men of African 
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descent (71.1). Immigrants from other low-income countries, e.g. East (26.8) and South 
(28.4) Asia, showed the lowest ASRs for prostate cancer (Figure 4).  
For breast cancer, Nordic (73.7) and other Western European (76.5) women had 
higher ASRs than Norwegian-born women (65.4), who had similar ASRs to women from the 
Middle East (61.3) and Eastern Europe (60.7). The lowest ASRs were found in women from 
low-income countries, e.g. East (41.8) and South (50.0) Asia and Sub-Saharan Africa (50.1) 
(Figure 4). Cervical cancer ASR for Norwegian-born (9.9) was higher than for all immigrants 
combined (8.2) (Figure 4).  
The highest ASRs for stomach cancer (Figure 5) were found among immigrants from 
Eastern Europe (13.4 in men and 7.5 in women), as compared to ASRs in Norwegian-born 
men (8.5) and women (4.2). For liver cancer (Figure 6), the ASRs for immigrants from low-
income countries exceeded the ASRs for Norwegian-born men and women. The highest 
ASRs were found in East Asian (19.7) and Sub-Saharan (15.3) men and in Asian (6.3) and 
Sub-Saharan (6.1) women. 
To further compare the incidence rates, we calculated SIRs (Supplementary Table 1 
and Supplementary Table 2). The results showed lower total cancer incidence among 
immigrants from low-income countries (SIRs from 0.48 in men and 0.64 in women from 
South Asia to 0.69 in men and 0.78 in women from Sub-Saharan Africa), compared with the 
Norwegian-born population. Men from Eastern Europe had high risk of lung cancer (SIR 
1.54), and Eastern European men (SIR 1.74) and women (SIR 1.86) had high risk of stomach 
cancer. Immigrants from low-income countries had higher risk of liver cancer than 








Our findings show that during the period 1990-2012, all immigrants to Norway 
combined had lower total cancer incidence than Norwegian-born, with differences between 
immigrant groups and cancer types. While incidence of breast and colorectal cancer were 
highest among individuals born in Norway and other high-income countries, other cancer 
types were higher in immigrants from low-income countries. We found an elevated incidence 
of lung cancer among Eastern European men, followed by men from the Nordic countries. 
We also found a high incidence of stomach cancer in immigrants from Eastern Europe. 
Immigrants from low-income countries (Asia and Sub-Saharan Africa) had high incidence of 
liver cancer.  
The elevated incidence of lung cancer in Eastern European men is likely entirely 
determined by smoking habits in the immigrant groups, which partly reflect smoking 
prevalence in their countries of origin (24). The high lung cancer incidence among Nordic 
immigrant men in Norway could reflect a selection of working class immigrants with high 
smoking prevalence (25). The high incidence of stomach cancer in immigrants from Eastern 
Europe may be caused by an Helicobacter pylori infection contracted in their country of 
origin (26) in combination with smoking (27). The very high liver cancer incidence found in 
immigrants from low-income countries is possibly caused by a hepatitis B or C virus 
infection (28). Immigrants from these countries tend to have high incidence of cancers related 
to exposure to infectious agents (2), and increased incidence of liver cancer has been found in 
Asian immigrants to Australia (29) and North America (21), and Sub-Saharan immigrants to 
France (30).  
On the other hand, incidences of lifestyle-related cancers, such as breast and 
colorectal cancer, were highest in individuals born in Norway and other high-income 
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countries, probably linked to a high-income lifestyle (i.e. diet, obesity, and physical 
inactivity) (31) and reproductive histories (32). The lower rates of breast cancer in women 
from low-income countries could also to some extent reflect poor utilization of Norwegian 
health care services, i.e. low attendance to mammographic screening (33-35). A surprising 
finding was the high incidence of cervical cancer in women born in Norway and the other 
Nordic countries, compared to most immigrant groups. The incidence of cervical cancer 
decreases following screening if pre-cancerous cell changes are found and treated before the 
disease is developed, and results from a recent study of attendance to screening in Norway 
have shown that the rates are generally lower for immigrants (36). Additionally, many 
Muslim countries have low rates of cervical cancer (1). The number of cervical cancer cases 
are relatively small in many immigrant groups, and results should be interpreted with caution. 
In general, our findings confirm findings of other recent studies of immigrants from 
low-income to high-income countries. The differences in cancer rates overall and in specific 
cancer types are likely due to a combination of different factors, such as differences in 
lifestyle and socioeconomic factors, reason for immigration, and the ‘healthy migrant effect’.  
Certain lifestyle factors associated with cancer risk may differ between immigrants 
and host populations. In particular, diet may be healthier and the prevalence of obesity and 
alcohol consumption lower in immigrants than in some high-income host populations before 
and immediately after arrival (37-39). On the other hand, self-reported physical inactivity 
tend to be higher in immigrants compared to the host population in Norway (40), and 
smoking prevalence is very high in some immigrant groups (41).  
After moving to the host country, immigrants go through various degrees of 
acculturation. Many factors, e.g. socioeconomic status and occupation, can influence the 
acculturation process (42), and affect cancer incidence. Immigrants from low- income 
countries are likely to have lower socioeconomic status than Norwegian-born (43), and they 
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are over-represented in occupations where they could be exposed to factors associated with 
cancer (25, 44). In addition, widespread high-income diets and increasing obesity prevalence 
worldwide could influence acculturation in recent immigrants (11).   
Variation in cancer incidence could also be linked to reason for immigration, which 
may vary across immigrant groups (12). In 2014, reasons for immigration to Norway were 
reported as due to labour (43%), family reunion (33%), refugees (14%) and students (10%). 
Labour immigrants mostly originate from Europe, while immigrants from Asia and Africa are 
typically refugees or family immigrants (45). The reason for immigration vary across gender. 
There is a male overrepresentation among refugees and labour immigrants and a female 
overrepresentation among family immigrants (46).   
The ‘healthy migrant effect’, in which immigrants are assumed to be healthier than the 
average population in the country of origin (10), does not appear to be supported by the 
results, as cancer incidence in immigrants from high-income countries is very similar to that 
of the Norwegian-born population. On the contrary, smoking rates may be higher in 
immigrants from some countries than in the population that remains, on the basis that they are 
a selected group, i.e. labour immigrants with high smoking prevalence.  
 
 
Strengths and limitations 
A strength of the study was the large study population, consisting of the entire Norwegian 
population between the years 1990-2012. The design enabled us to identify accurately all 
immigrants in Norway, from many regions around the world, and to follow them 
prospectively. Another strength was the complete cancer registration. 
A limitation of the study was the size of the different immigrant groups, comprising a 
relatively small proportion of the entire Norwegian population and producing at times 
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uncertain effect estimates. We included individuals born in Norway of immigrant parents in 
the Norwegian-born population, but if they have rates in between immigrants and 
Norwegian-born with Norwegian-born parents, then the differences may have been 
underestimated. However, this was a small group, consisting of young individuals not yet 
reached the age where cancer normally occur. The immigrant groups identified in this study 
are often heterogeneous and diverse, and could mask variations by country of origin, however 
investigating group differences still have empirical value. Additionally, immigration patterns 
to Norway have shifted over time, and older and younger immigrants, with different reason 
for immigration, originate from different countries. To disentangle the effect of age, calendar 
period, and region of origin, we calculated age- and period-specific ASRs, and adjusted for 
age in 5-year categories and time period in 5-year intervals.   
The extent to which missing or incorrect emigration data may have influenced our 
results could not be examined. Some immigrants may emigrate back to their country of origin 
and fail to notify the Norwegian population registry, and thus their vital statistics remain 
‘cancer free and immortal’. In some cases, an emigration is registered in the system several 
years after the person actually left the country (47). 70% of the registered emigrations 
(22 883 individuals) were attributed to immigrants in 2011, mostly from the Nordic or other 
Western European countries (48). The ‘salmon bias’ hypothesis suggests that as immigrants 
age or fall ill they migrate back to their country of origin to die (49). However, health 
services and treatment are most likely better in Norway, and many immigrants have already 
been joined by their families.  
The adult immigrant population in Norway is relatively young, especially immigrants 
from low-income countries, and have not yet reached the age groups characterized with high 
lung, colorectal, and prostate cancer rates. This is especially the case for prostate cancer, 
where 85% of cases are diagnosed after the age of 65 years, after which ASR increase with 
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age (50). However, the ASRs presented in our study are standardized, i.e. adjusted for the 
effect of differences in age-distribution across populations. The rates are weighted averages 





This study showed that total cancer incidence was lower in immigrants than in Norwegian-
born, with differences in incidence patterns depending on country of origin and the cancer 
type in question. The extent of the differences varied across gender and immigrant groups. 
Immigrants from high-income countries had a relatively similar cancer burden compared to 
Norwegian-born, with high incidence of lifestyle-related cancers. The high incidence of lung 
cancer among Eastern European men, and to some extent among men from other Nordic 
countries, is a main concern, and current tobacco control should attempt to reach these 
populations. Immigrants from Eastern Europe also have high rates of stomach cancer. 
Additional attention should be given to the high rates of liver cancer among immigrants from 
low-income countries.  It is important that health care personnel are attentive of symptoms of 
these cancers that, although rare, are present in some immigrant groups. Since immigrants 
constitute a significant and increasing proportion of the population in many high-income 
countries, monitoring their cancer rates and health needs can indicate the extent of risk 
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Figure 1. Age-standardized incidence rates (ASR) with 95% confidence intervals (CIs) for 
total (C00-96) minus non-melanoma skin (C44) cancer by birth region. Standardized by the 
world standard population. Adjusted for calendar period (in 5-year intervals) and age (in 5-
year categories). 
Figure 2. Age-standardized incidence rates (ASR) with 95% confidence intervals (CIs) for 
lung cancer (C33-34) by birth region. Standardized by the world standard population. 
Adjusted for calendar period (in 5-year intervals) and age (in 5-year categories). 
Figure 3. Age-standardized incidence rates (ASR) with 95% confidence intervals (CIs) for 
colorectal cancer (C18-20) by birth region. Standardized by the world standard population. 
Adjusted for calendar period (in 5-year intervals) and age (in 5-year categories). 
Figure 4. Age-standardized incidence rates (ASR) with 95% confidence intervals (CIs) for 
prostate (C61), breast (C50), and cervical cancer (C53) by birth region. Standardized by the 
world standard population. Adjusted for calendar period (in 5-year intervals) and age (in 5-
year categories). 
Figure 5. Age-standardized incidence rates (ASR) with 95% confidence intervals (CIs) for 
stomach cancer (C16) by birth region. Standardized by the world standard population. 
Adjusted for calendar period (in 5-year intervals) and age (in 5-year categories). 
Figure 6. Age-standardized incidence rates (ASR) with 95% confidence intervals (CIs) for 
liver cancer (C22) by birth region. Standardized by the world standard population. Adjusted 
for calendar period (in 5-year intervals) and age (in 5-year categories).  





 Cases Personyears ASR (95% CI)  
Total cancer, men     
 
Norway 263 316 52 957 621 298.3 (297.1-299.5) 
All immigrants 9 158 3 568 665 266.8 (260.8-272.8) 
Immigrants from    
Other Nordic countries 2 737 577 832 298.9 (286.9-311.5) 
Other Western Europe 1 858 480 144 290.8 (275.9-306.6) 
Eastern Europe 1 770 835 512 276.1 (262.0-290.8) 
Middle East 520 421 128 202.9 (180.6-227.1) 
South Asia 477 415 340 146.7 (130.9-164.1) 
East Asia 406 254 710 192.2 (170.3-216.3) 
Sub-Saharan Africa 326 293 266 224.8 (194.4-258.4) 
Rest Africa 34 20 144 381.4 (202.0-640.2) 
USA, Canada  652 99 013 251.4 (224.7-281.7) 
Oceania 38 13 793 365.9 (249.7-534.9) 
South/Central America 257 126 489 288.5 (247.1-335.0) 
Total cancer, women     
Norway 235 020 53 873 413 248.8 (247.6-249.9) 
 
All immigrants 10 334 3 473 083 235.1 (230.0-240.4) 
Immigrants from    
Other Nordic countries 3 172 659 294 249.8 (240.2-260.0) 
Other Western Europe 2 018 409 679 247.4 (233.6-261.9) 
Eastern Europe 1 825 754 429 254.3 (241.0-268.1) 
Middle East 396 278 443 191.1 (168.3-216.1) 
South Asia 522 339 703 168.0 (151.2-186.4) 
East Asia 838 462 198 181.2 (166.9-196.8) 
Sub-Saharan Africa 316 240 746 204.2 (176.9-234.3) 
Rest Africa 15 9 978 178.2 (85.1-330.0) 
USA, Canada 772 123 768 224.8 (205.1-247.5) 
Oceania 54 12 175 299.3 (222.2-423.9) 
South/Central America 294 148 193 197.9 (168.8-231.0) 
 
 
 Cases Personyears ASR (95% CI)  
Lung cancer, men     
Norway 30 286 52 957 621 33.3 (33.0-33.7) 
 
All immigrants 1 251 3 568 665 37.4 (35.3-39.6) 
Immigrants from    
Other Nordic countries 386 577 832 41.6 (37.5-46.3) 
Other Western Europe 223 480 144 35.0 (30.4-40.3) 
Eastern Europe 315 835 512 50.7 (44.9-57.2) 
Middle East 55 421 128 25.5 (17.7-35.5) 
South Asia 59 415 340 19.9 (14.1-27.5) 
East Asia 63 254 710 29.3 (22.2-38.4) 
Sub-Saharan Africa 23 293 266 20.1 (11.6-32.0) 
USA, Canada 86 99 013 30.8 (23.8-41.9) 
Lung cancer, women     
Norway 18 689 53 873 413 19.1 (18.8-19.4) 
 
All immigrants 724 3 473 083 17.1 (15.8-18.5) 
Immigrants from    
Other Nordic countries 261 659 294 19.0 (16.7-22.1) 
Other Western Europe 176 409 679 19.2 (16.3-23.0) 
Eastern Europe 113 754 429 17.7 (14.4-21.5) 
Middle East 9 278 443 6.3 (2.6-12.8) 
South Asia 16 339 703 6.3 (3.3-11.2) 
East Asia 54 462 198 17.9 (13.1-24.4) 
Sub-Saharan Africa 14 240 746 14.8 (7.5-25.5) 
USA, Canada 56 123 768 16.4 (11.6-25.6) 
 
 
 Cases Personyears ASR (95% CI)  
Colorectal cancer, men     
 
Norway 36 463 52 957 621 38.8 (38.4-39.3) 
All immigrants 979 3 568 665 28.8 (27.0-30.8) 
Immigrants from    
Other Nordic countries 314 577 832 33.4 (29.8-37.8) 
Other Western Europe 212 480 144 33.3 (28.9-38.7) 
Eastern Europe 188 835 512 31.0 (26.4-36.2) 
Middle East 44 421 128 18.3 (11.7-27.0) 
South Asia 27 415 340 7.2 (3.7-12.7) 
East Asia 44 254 710 21.3 (15.2-29.5) 
Sub-Saharan Africa 21 293 266 15.0 (7.2-26.7) 
USA, Canada 83 99 013 28.1 (21.4-39.1) 
Colorectal cancer, women     
Norway 36 521 53 873 413 30.7 (30.4-31.1) 
 
All immigrants 1 098 3 473 083 23.6 (22.2-25.1) 
Immigrants from    
Other Nordic countries 395 659 294 26.1 (23.4-29.4) 
Other Western Europe 251 409 679 25.7 (22.4-29.8) 
Eastern Europe 172 754 429 25.3 (21.4-30.0) 
Middle East 17 278 443 11.4 (6.3-19.0) 
South Asia 30 339 703 9.2 (5.8-14.3) 
East Asia 64 462 198 19.4 (14.4-26.0) 
Sub-Saharan Africa 19 240 746 15.2 (8.6-24.7) 
USA, Canada 101 123 768 19.8 (14.8-29.1) 
 
 Cases Personyears ASR (95% CI)  
Prostate cancer     
Norway 74 156 52 957 621 78.5 (77.9-79.1) 
 
All immigrants 1 894 3 568 665 61.0 (58.2-63.8) 
Immigrants from    
Other Nordic countries 657 577 832 70.4 (65.1-76.4) 
Other Western Europe 429 480 144 70.4 (63.8-77.9) 
Eastern Europe 264 835 512 50.6 (44.5-57.3) 
Middle East 71 421 128 43.2 (32.4-56.3) 
South Asia 71 415 340 28.4 (21.7-36.8) 
East Asia 46 254 710 26.8 (19.4-36.3) 
Sub-Saharan Africa 67 293 266 71.1 (53.4-92.4) 
USA, Canada 193 99 013 64.5 (54.3-78.3) 
Breast cancer, women     
Norway 54 866 53 873 413 65.4 (64.8-66.0) 
 
All immigrants 2 943 3 473 083 65.8 (63.4-68.4) 
Immigrants from    
Other Nordic countries 881 659 294 73.7 (68.7-79.2) 
Other Western Europe 615 409 679 76.5 (70.4-83.4) 
Eastern Europe 483 754 429 60.7 (55.0-66.9) 
Middle East 151 278 443 61.3 (50.2-74.4) 
South Asia 170 339 703 50.0 (41.8-60.0) 
East Asia 228 462 198 41.8 (35.7-49.3) 
Sub-Saharan Africa 88 240 746 50.1 (37.7-65.1) 
USA, Canada 193 123 768 71.7 (60.2-86.6) 
Cervical cancer     
Norway 6 925 53 873 413 9.9 (9.7-10.2) 
 
All immigrants 400 3 473 083 8.2 (7.4-9.1) 
Immigrants from    
Other Nordic countries 115 659 294 10.6 (8.8-13.3) 
Other Western Europe  54 409 679 7.3 (5.4-10.3) 
Eastern Europe 92 754 429 8.9 (7.0-11.2) 
Middle East 10 278 443 4.4 (1.8-9.5) 
South Asia 16 339 703 5.8 (3.0-10.5) 
East Asia 65 462 198 11.4 (8.3-16.2) 
Sub-Saharan Africa 9 240 746 5.0 (1.7-11.3) 
USA, Canada  14 123 768 5.4 (2.6-13.9) 
 
 
 Cases Personyears ASR (95% CI)  
Stomach cancer, men     
 
Norway 8 315 52 957 621 8.5 (8.3-8.7) 
All immigrants 320 3 568 665 9.2 (8.2-10.3) 
Immigrants from    
Other Nordic countries 89 577 832 9.5 (7.6-12.2) 
Other Western Europe 45 480 144 6.5 (4.7-9.4) 
Eastern Europe 86 835 512 13.4 (10.5-16.8) 
Middle East 17 421 128 5.8 (2.8-11.0) 
South Asia 13 415 340 3.6 (1.6-7.8) 
East Asia 18 254 710 8.4 (4.8-14.3) 
Sub-Saharan Africa 14 293 266 11.9 (6.1-20.9) 
USA, Canada 17 99 013 5.9 (3.1-14.5) 
Stomach cancer, women     
Norway 5 504 53 873 413 4.2 (4.1-4.4) 
 
All immigrants 202 3 473 083 4.3 (3.7-5.0) 
Immigrants from    
Other Nordic countries 43 659 294 2.9 (2.1-4.8) 
Other Western Europe 30 409 679 3.0 (1.9-5.2) 
Eastern Europe 49 754 429 7.5 (5.5-10.2) 
Middle East 8 278 443 7.7 (2.8-16.1) 
South Asia 14 339 703 4.6 (2.3-8.6) 
East Asia 21 462 198 6.3 (3.7-11.0) 
Sub-Saharan Africa 4 240 746 3.0 (0.5-9.0) 
USA, Canada 28 123 768 6.9 (3.9-15.2) 
 
 
 Cases Personyears ASR (95% CI)  
Liver cancer, men     
 
Norway 1 677 52 957 621 1.9 (1.8-2.0) 
All immigrants 201 3 568 665 5.6 (4.7-6.6) 
Immigrants from    
Other Nordic countries 33 577 832 5.2 (2.1-10.2) 
Other Western Europe 23 480 144 3.3 (2.1-5.7) 
Eastern Europe 17 835 512 2.8 (1.5-4.6) 
Middle East 6 421 128 3.1 (1.0-7.7) 
South Asia 28 415 340 8.6 (5.4-13.6) 
East Asia 52 254 710 19.7 (14.4-27.1) 
Sub-Saharan Africa 26 293 266 15.3 (8.5-25.3) 
USA, Canada 7 99 013 3.5 (1.3-12.1) 
Liver cancer, women     
Norway 1 096 53 873 413 1.0 (0.9-1.0) 
 
All immigrants 99 3 473 083 2.5 (1.8-3.4) 
Immigrants from    
Other Nordic countries 18 659 294 1.1 (0.6-2.8) 
Other Western Europe 12 409 679 3.3 (0.7-8.7) 
Eastern Europe 18 754 429 3.6 (1.8-6.3) 
Middle East 0 278 443 - 
South Asia 13 339 703 6.3 (3.2-11.5) 
East Asia 23 462 198 6.3 (3.7-10.8) 
Sub-Saharan Africa 7 240 746 6.1 (2.1-13.4) 
USA, Canada 5 123 768 0.6 (0.1-9.0) 
 
